BioSpace News Archive

Business

Hugo Petit Appointed CFO of OxThera

OxThera AB today announced the appointment of Hugo Petit as its new Chief Financial Officer. Mr Petit previously served as the Chief Financial Officer of MedCap AB.

September 7, 2018
·
1 min read
Drug Development

Botanix Pharmaceuticals Preliminary Final Report

Successfully completed the BTX 1530 Phase 1b acne patient and advanced into Phase 2 clinical development in June 2108

September 7, 2018
·
1 min read
New PBS listing for Leukaemia Drug ICLUSIG® (ponatinib)

ICLUSIG to be made available to all refractory/relapsed Ph+ ALL patients from September 1, 2018

September 7, 2018
·
10 min read
Business

AusCann Makes Major Process Towards Production of Cannabinoid Medicines during FY18

Appendix 4E and Preliminary Final Report

September 7, 2018
·
1 min read
Deals

Thermo Fisher Scientific to Acquire Advanced Bioprocessing Business from BD

Thermo Fisher Scientific Inc. has signed a definitive agreement with BD (Becton, Dickinson and Company)

September 7, 2018
·
2 min read
Deals

BD Statement on Divestiture of Advanced Bioprocessing Business

BD (Becton, Dickinson and Company) (NYSE: BDX) today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific

September 7, 2018
·
3 min read
Midatech Announces Interim Results from Proof of Concept Exploratory Study for its MTD201 Q-Octreotide Programme and Q-Sphera™ Microsphere Technology

Interim data for key oncology drug candidate MTD201 establishes favourable clinical profile compared to reference product Novartis’ Sandostatin® LAR® (“SLAR”)

September 7, 2018
·
8 min read
GENFIT announces its upcoming participation in a number of investor and NASH-specific events over the next two months

GENFIT today announces its participation in numerous investor healthcare conferences both in Europe and the United States.

September 7, 2018
·
6 min read
Business

Medigene AG: Medigene announces change in executive leadership team

Planegg announced today that the Chief Financial Officer (CFO), Dr. Thomas Taapken, will leave the Company for personal reasons and will resign from his CFO position effective August 31, 2018.

September 7, 2018
·
2 min read
Pharm Country

Capstone Headwaters Advises Aequor Healthcare Services on its Recapitalization with DW Healthcare Partners

Capstone Headwaters LLC announced that it has successfully advised Aequor Healthcare Services on its recapitalization with DW Healthcare Partners

September 7, 2018
·
3 min read